172 related articles for article (PubMed ID: 35731142)
1. Upregulated expression of FFAR2 and SOC3 genes is associated with gout.
Orji OC; López-Domínguez MB; Sandoval-Plata G; Guetta-Baranes T; Valdes AM; Doherty M; Morgan K; Abhishek A
Rheumatology (Oxford); 2023 Feb; 62(2):977-983. PubMed ID: 35731142
[TBL] [Abstract][Full Text] [Related]
2. Monosodium urate burden assessed with dual-energy computed tomography predicts the risk of flares in gout: a 12-month observational study : MSU burden and risk of gout flare.
Pascart T; Grandjean A; Capon B; Legrand J; Namane N; Ducoulombier V; Motte M; Vandecandelaere M; Luraschi H; Godart C; Houvenagel E; Norberciak L; Budzik JF
Arthritis Res Ther; 2018 Sep; 20(1):210. PubMed ID: 30223875
[TBL] [Abstract][Full Text] [Related]
3. [Risk factors and diagnostic value for ultrasound-detected tendon monosodium urate crystal deposition in patients with gout].
Wang Y; Deng XR; Ji LL; Zhang XH; Geng Y; Zhang ZL
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 53(1):143-149. PubMed ID: 33550349
[TBL] [Abstract][Full Text] [Related]
4. Brief Report: Monosodium Urate Monohydrate Crystal Deposits Are Common in Asymptomatic Sons of Patients With Gout: The Sons of Gout Study.
Abhishek A; Courtney P; Jenkins W; Sandoval-Plata G; Jones AC; Zhang W; Doherty M
Arthritis Rheumatol; 2018 Nov; 70(11):1847-1852. PubMed ID: 29806203
[TBL] [Abstract][Full Text] [Related]
5. Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study.
Uhlig T; Karoliussen LF; Sexton J; Kvien TK; Haavardsholm EA; Perez-Ruiz F; Hammer HB
Clin Rheumatol; 2022 Dec; 41(12):3817-3823. PubMed ID: 36316609
[TBL] [Abstract][Full Text] [Related]
6. The epigenome: key to understanding and predicting gout flares.
Wolyncewicz B; Major TJ; Delahunt B; Thunders M
Pathology; 2021 Dec; 53(7):824-829. PubMed ID: 34657735
[TBL] [Abstract][Full Text] [Related]
7. Variability in the Reporting of Serum Urate and Flares in Gout Clinical Trials: Need for Minimum Reporting Requirements.
Stamp LK; Morillon MB; Taylor WJ; Dalbeth N; Singh JA; Lassere M; Christensen R
J Rheumatol; 2018 Mar; 45(3):419-424. PubMed ID: 29247147
[TBL] [Abstract][Full Text] [Related]
8. Differences in MSU-induced superoxide responses by neutrophils from gout subjects compared to healthy controls and a role for environmental inflammatory cytokines and hyperuricemia in neutrophil function and survival.
Martin WJ; Grainger R; Harrison A; Harper JL
J Rheumatol; 2010 Jun; 37(6):1228-35. PubMed ID: 20395644
[TBL] [Abstract][Full Text] [Related]
9. Ultrasonography in the prediction of gout flares: a 12-month prospective observational study.
Cipolletta E; Abhishek A; Di Battista J; Grassi W; Filippucci E
Rheumatology (Oxford); 2023 Mar; 62(3):1108-1116. PubMed ID: 35920773
[TBL] [Abstract][Full Text] [Related]
10. Clinical features of gout.
Grassi W; De Angelis R
Reumatismo; 2012 Jan; 63(4):238-45. PubMed ID: 22303530
[TBL] [Abstract][Full Text] [Related]
11. Investigation on monosodium urate deposition in the first metatarsophalangeal joint and ankle of primary gout patients using dual-energy computed tomography.
Tam V; Nam VT; Quoc TAH
Med J Malaysia; 2022 May; 77(3):279-283. PubMed ID: 35638482
[TBL] [Abstract][Full Text] [Related]
12. Does seasonality of the microbiota contribute to the seasonality of acute gout flare?
Schlesinger N; Brunetti L; Androulakis IP
Clin Exp Rheumatol; 2022 Sep; 40(9):1793-1800. PubMed ID: 35383564
[TBL] [Abstract][Full Text] [Related]
13. Uric acid en route to gout.
Zhang WZ
Adv Clin Chem; 2023; 116():209-275. PubMed ID: 37852720
[TBL] [Abstract][Full Text] [Related]
14. [Gout].
Tausche AK
Z Rheumatol; 2022 Jun; 81(5):400-412. PubMed ID: 35596003
[TBL] [Abstract][Full Text] [Related]
15. Ultrasonography shows disappearance of monosodium urate crystal deposition on hyaline cartilage after sustained normouricemia is achieved.
Thiele RG; Schlesinger N
Rheumatol Int; 2010 Feb; 30(4):495-503. PubMed ID: 19543895
[TBL] [Abstract][Full Text] [Related]
16. [Gout].
Tausche AK
Internist (Berl); 2021 May; 62(5):513-525. PubMed ID: 33721041
[TBL] [Abstract][Full Text] [Related]
17. Overview of Serum Uric Acid Treatment Targets in Gout: Why Less Than 6 mg/dL?
Ruoff G; Edwards NL
Postgrad Med; 2016 Sep; 128(7):706-15. PubMed ID: 27558643
[TBL] [Abstract][Full Text] [Related]
18. Role of miR-146a in regulation of the acute inflammatory response to monosodium urate crystals.
Dalbeth N; Pool B; Shaw OM; Harper JL; Tan P; Franklin C; House ME; Cornish J; Naot D
Ann Rheum Dis; 2015 Apr; 74(4):786-90. PubMed ID: 25646371
[TBL] [Abstract][Full Text] [Related]
19. MSU crystal deposition contributes to inflammation and immune responses in gout remission.
Gu H; Yu H; Qin L; Yu H; Song Y; Chen G; Zhao D; Wang S; Xue W; Wang L; Ai Z; Xu B; Peng A
Cell Rep; 2023 Oct; 42(10):113139. PubMed ID: 37756161
[TBL] [Abstract][Full Text] [Related]
20. Systemic inflammatory cytokine profiles in patients with gout during flare, intercritical and treat-to-target phases: TNFSF14 as new biomarker.
Ea HK; Kischkel B; Chirayath TW; Klück V; Aparicio C; Loeung HU; Manivet P; Jansen T; Zarka M; Lioté F; Latourte A; Bardin T; Gauffenic A; Vicaut E; Crișan TO; Netea MG; Richette P; Joosten LA
Ann Rheum Dis; 2024 Jun; 83(7):945-956. PubMed ID: 38373842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]